Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onsetSeizures (a type of epilepsy of fits) who had participated in study P09-004.
Phase 3
Completed
- Conditions
- Health Condition 1: null- Refractory Partial-Onset Seizures
- Registration Number
- CTRI/2012/06/002721
- Lead Sponsor
- psherSmith Laboratories Inc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 172
Inclusion Criteria
1. Have completed the maintenance period of the P09-004 study.
2. Continue to be treated with a stable dose of 1 to a maximum of 3 approved concomitant AEDs.
Exclusion Criteria
NA
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method